This study is completed in the United States and in the United Kingdom. It is testing BNC210 for PTSD.
PTSDDrugFrom 18 Years to 75 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether BNC210 Tablet Formulation may be useful for adults experiencing ptsd.
What would participation involve?
Participants may receive BNC210 Tablet Formulation, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United Kingdom and in the United States.
Who is it mainly for?
This study appears to be mainly for adults with ptsd.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: July 27, 2021
Recruitment status
Completed
Enrollment listed in the registry
212
Sponsor
Bionomics Limited
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, United Kingdom
Age range
From 18 Years to 75 Years
Official registry ID
NCT04951076
Official title
A Phase 2b, Randomized, Double Blind, Two Arm Study to Investigate the Effects of BNC210 Tablet Formulation Compared to Placebo in Adults With Post-Traumatic Stress Disorder (PTSD)
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT04951076. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United Kingdom · 7 sites
ATTUNE Study Clinical Trial Site
Barnsley
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Blackpool
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Cannock
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Leeds
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Liverpool
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Manchester
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Stockton-on-Tees
Site status: Not listed — confirm with the team
United States · 25 sites
ATTUNE Study Clinical Trial Site
Bellflower, California
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Beverly Hills, California
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Colton, California
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Oceanside, California
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Orange, California
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Temecula, California
Site status: Not listed — confirm with the team
ATTTUNE Study Clinical Trial Site
Jacksonville, Florida
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Lauderhill, Florida
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Miami Lakes, Florida
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Orlando, Florida
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Overland Park, Kansas
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Prairie Village, Kansas
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
New Bedford, Massachusetts
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Las Vegas, Nevada
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Berlin, New Jersey
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Cherry Hill, New Jersey
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Cedarhurst, New York
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Staten Island, New York
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
North Canton, Ohio
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
West Chester, Pennsylvania
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Memphis, Tennessee
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Austin, Texas
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Dallas, Texas
Site status: Not listed — confirm with the team
ATTUNE Study Clinical Trial Site
Draper, Utah
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
Based on the public registry summary, this study is trying to understand: The purpose of this study is to assess the effects of BNC210 compared to placebo on Post-Traumatic Stress Disorder (PTSD) symptom severity as measured by the Clinician Administered PTSD scale for The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). The study team can confirm the exact objective and what it means for you.
Does this study involve a medication?
This appears to be a medication / drug study involving BNC210, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with ptsd; age range: From 18 Years to 75 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Bionomics Limited, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
